Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04362631 · ClinicalTrials.gov registry record
Respiratory Infection Monitoring
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 42
- Enrollment target
NCT04362631: Completed study, sponsored by Northwestern University.
NCT04362631 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04362631 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
This study will monitor physical bio-markers such as heart rate, respiratory rate, and temperature to detect potential respiratory infections.
Primary Outcome
Device data measuring cough count. Captured by analysis of peak acclerometer graphing and duration in meters per second squared (m/s2).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2020-04-24 |
| Est. Completion | 2022-09-06 |
What the finished NCT04362631 record still lists
NCT04362631 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04362631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04362631 about?
NCT04362631 is a clinical study titled "Respiratory Infection Monitoring". This study will monitor physical bio-markers such as heart rate, respiratory rate, and temperature to detect potential respiratory infections.
What is the current status of trial NCT04362631?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2020-04-24. Estimated completion is 2022-09-06.
Who is sponsoring clinical trial NCT04362631?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI